India Inc. How India's Top Ten Entrepreneurs are Winning Globally | by Vikas Pota

quotes
You are here: Home India Inc - The Interviews Malvinder Singh
E-mail Print PDF

Malvinder Singh
Doubled profits as CEO of Ranbaxy, India’s largest pharma company, producing drugs whose patents have expired (generics) at lower cost.

  • Masterminded acquisitions that brought scale to Ranbaxy and resulted in its ascent to the global top 10 generics companies, with sales of $1.7 billion and exports to 150 countries.
  • Sold his family’s stake for approx. $4 billion to a Japanese pharma company, thus creating the world’s first “hybrid” drugs manufacturer.
  • Now leads the family’s businesses in healthcare and financial services as Group Chairman of Religare.
  • All this before the age of 40!

 

Other India Inc Interviews:


 


Sign up for Vikas' email updates
about the book & as a BONUS get free
access to the introductory chapter
of India Inc.

 


* indicates required
 

Buy the Book